KEDI Palantir Fixed Tech100 Index

Q2 2026 earnings release on June 4, 2026; a Medium impact is estimated as quarterly earnings are key drivers of stock volatility, scheduled.

Next earnings release for Q4 fiscal 2026 on June 1, 2026, scheduled.

U.S. FDA PDUFA action date for the subcutaneous formulation of LEQEMBI for treatment initiation in early Alzheimer's disease is scheduled. This regulatory milestone is estimated to have a medium impact on stock price.

Biogen's Q1 2026 earnings release is expected around this date, based on past reporting schedules. Earnings releases typically result in moderate price volatility.

Natera is expected to report its Q1 2026 earnings on May 7, 2026, with analysts forecasting an EPS of approximately -$0.55. Market impact is estimated at ≥1% as earnings dates are routine; scheduled.

AppLovin's Q1 2026 earnings release is scheduled.

Q4 Fiscal Year 2026 earnings release including guidance for net sales of $1.26 billion +/- $20 million and non-GAAP diluted EPS of $0.48–$0.52. Low importance estimated as guidance is within expected ranges scheduled.

First quarter 2026 earnings release expected; analysts forecast revenue of $9.83B and EPS of $1.18-$1.27 forecasted.

Q3 fiscal year 2026 earnings release is scheduled.

Linde's Q1 2026 earnings release is scheduled for April 30, 2026; analysts forecast EPS of $4.27, with a medium impact expected as earnings reports are key volatility drivers, forecasted.

Alnylam Q1 2026 financial results announcement, with an estimated market impact of ≥1% based on historical quarterly volatility, expected

Automatic Data Processing (ADP) is scheduled to release its financial results for the third fiscal quarter ending March 31, 2026, on April 29, 2026, before the market opens. Importance is estimated based on the potential for a significant market reaction to the earnings data, scheduled

Q2 2026 earnings release is scheduled. Analysts forecast EPS of approximately $2.56-$2.58. This event is estimated to have a medium price impact of approximately 5-7% based on historical volatility forecasted.

Regeneron will report its first quarter 2026 financial and operating results before the U.S. financial markets open; medium importance reflects an estimated price impact of 5% or more, scheduled.

NXP Semiconductors is scheduled to release its financial results for the first quarter of 2026 after market close; high importance estimated due to historical earnings volatility, scheduled.

Q1 2026 earnings release on 2026-04-27 is scheduled. This event is estimated to have a low impact (≥1%) as a routine announcement, scheduled.

Sanofi's Q1 2026 financial results release on 2026-04-23. Estimated importance based on typical market reaction to quarterly earnings scheduled.

Comcast's Q1 2026 earnings release is scheduled. Analysts at BofA Securities have forecasted a potential 12% year-over-year decline in consolidated EBITDA to $7.7 billion, and an EPS of $0.71, citing costs related to NBA content. A low price impact is estimated as the market has likely priced in the NBA content costs.

Honeywell's first-quarter 2026 earnings results are scheduled to be released on 2026-04-23 scheduled.

Intel's Q1 2026 earnings release is scheduled for April 23, 2026, with analysts forecasting EPS of $0.01 and revenues of $11.7B-$12.7B; this is estimated to have a >=1% price impact and is scheduled.

Q1 2026 earnings release for after market close on April 21, 2026, scheduled.

Q1 2026 earnings release; low importance as the announcement of the date itself typically impacts price by >=1%, thus a minor reaction is scheduled.

Netflix Q1 2026 earnings release and business outlook on April 16, 2026, which is expected to cause >10% volatility based on historical earnings reactions scheduled.

The 2026 annual meeting of stockholders is scheduled for April 16, 2026. Low importance is estimated as annual meetings rarely result in immediate large price swings, scheduled.

Q1 2026 earnings release scheduled.

A 25-for-1 forward stock split will be effective, with the stock scheduled to begin trading on a split-adjusted basis on April 6, 2026, scheduled.

The ex-dividend date (2026-04-01) for a quarterly dividend of $0.33 per share. The dividend is payable on April 22, 2026.

Announced a cross-license and settlement agreement with Molex, LLC on March 26, 2026, ending all patent disputes. High importance estimated due to the resolution of significant legal uncertainty.

Netflix announced a price increase for all of its US subscription plans, effective March 26, 2026. This is expected to have a >10% impact on revenue and stock price due to improved ARPU scheduled.

On March 26, 2026, William Blair downgraded Adobe stock to 'Market Perform' citing rising competition; a medium impact (>=5%) is estimated.

Stock fell approximately 7% on March 26, 2026, amid reports of concerns over e-commerce spending trends, customer churn, and short-seller allegations.

Announced a multi-year agreement with SoftBank Corp. to expand and modernize the operator's core network in Japan with Ericsson's dual-mode 5G Core solution; medium importance as this major contract is expected to impact price by >=5%, thus a positive reaction is expected.

On March 26, 2026, reports emerged that Microsoft suspended new hiring in major divisions to cut costs ahead of its fiscal year-end. This hiring freeze may signal concerns about slowing revenue growth, potentially weighing on investor sentiment by 1% or more, scheduled.

Announced an expansion of its global partnership with management consulting firm Bain & Company on March 26, 2026, to deepen AI collaboration and broaden client access to Palantir's platforms.

A New Mexico jury found Meta violated state consumer protection laws regarding child safety and ordered the company to pay $375 million in penalties on March 25, 2026.

A California jury found Meta liable for negligence in designing addictive platforms harmful to youth mental health on March 25, 2026, a landmark verdict that could influence thousands of similar cases.

PDD Holdings reported Q4 and full-year 2025 financial results on March 25, 2026. While Q4 revenue grew 12% YoY to RMB 123.9B, net income fell 11% YoY to RMB 24.5B, missing analyst estimates due to strategic supply chain investments. High importance is estimated as an 11% profit miss in the tech sector typically triggers ≥10% price impact, expected.

AMD plans to raise CPU prices by 10-15% in April 2026; medium importance as price hikes can drive ≥5% price impact scheduled.

Announced an integration with Chainlink to publish its premium exchange and derivatives data on-chain, aiming to enhance the infrastructure for DeFi protocols. This strategic partnership is estimated to result in a ≥5% price impact, scheduled.

Announced an expanded strategic collaboration with IBM to integrate CrowdStrike's Charlotte AI with IBM's Autonomous Threat Operations Machine (ATOM). Medium importance is estimated due to the scale of the partnership and integration with IBM's security ecosystem.

Intel reportedly informed customers of CPU price increases of 10-15% starting in March 2026; this margin-expanding move is estimated to have a >=5% price impact.

On Mar 25, 2026, Amazon announced the acquisition of Fauna Robotics; analysts estimate a 1% market impact from the strategic technology expansion, estimated.

Announced an expanded partnership with Intel to optimize the CrowdStrike Falcon platform for Intel-powered AI PCs. Low importance is estimated as it is an optimization partnership for specific hardware.

Announced the launch of 'Flex for Services', extending its flexible Falcon Flex consumption model to its security services portfolio. Low importance is estimated as it is an extension of an existing consumption model.

Announced an expansion of its affiliate partner program on Facebook to include major retailers like Amazon, eBay, and Temu on March 25, 2026, set to roll out in the coming months.

Micron announced cash tender offers for senior notes maturing 2031-2035 on 2026-03-25. Low importance due to ≥1% estimated impact; expected.

Received a record multi-year order of approximately $7.9 billion (€7.3 billion) from SK Hynix for EUV lithography systems, with deliveries extending through 2027.

Shopify announced the launch of Agentic Storefronts, enabling merchants to sell directly on major AI platforms including ChatGPT, Google's Gemini, and Microsoft's Copilot, activating this feature for millions of merchants by default. This major strategic expansion into AI-driven commerce is expected to significantly impact merchant GMV and market position.

During an investor webinar, Alnylam highlighted strong commercial momentum for its drug AMVUTTRA and reiterated its 2026 TTR revenue guidance of $4.4 billion to $4.7 billion. The company also announced strategic collaborations with Viz.ai and the American Heart Association to accelerate patient diagnosis.

Japan's Ministry of Health, Labour and Welfare (MHLW) approved Dupixent for the treatment of adults with moderate-to-severe bullous pemphigoid (BP), marking the drug's seventh approved indication in Japan. Medium importance reflects an estimated price impact of 5% or more due to market expansion.

Sanofi and Regeneron's Dupixent approval in Japan for bullous pemphigoid on 2026-03-24. Estimated importance based on market expansion for key drug scheduled.

Announced a Memorandum of Understanding with research center Forschungszentrum Jülich on March 24, 2026, to collaborate on developing advanced AI solutions for future 6G networks; low importance as MOUs typically impact price by >=1%, thus a minor reaction is expected.

Announced the general availability of Bits AI Security Analyst on March 23, 2026, an AI agent integrated into its Cloud SIEM. A 5% price impact is estimated due to the expansion of AI-driven security capabilities.

The Pentagon designated Palantir's Maven AI system as a 'program of record' on March 23, 2026, transitioning it from a pilot to a permanent, budget-backed program for weapons targeting across the U.S. military.

Announcement of Prisma Browser evolution for AI agents on March 23, 2026. Low importance estimated due to typical minor price impact of product updates, scheduled.

FDA labeling update for Fluzone safety information on 2026-03-23. Estimated importance based on potential safety concerns scheduled.